Cargando…

Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells

SIMPLE SUMMARY: The full activation of AKT, which is necessary for cell physiological changes, is achieved through the phosphorylation of Thr308 and Ser473 in human AKT. Here, we have addressed how AKT activation at early endosomes occurs during growth factor stimulation and how mTORC2 is recruited...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Suree, Heo, Sukyeong, Brzostowski, Joseph, Kang, Dongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157044/
https://www.ncbi.nlm.nih.gov/pubmed/34065746
http://dx.doi.org/10.3390/cancers13102405
_version_ 1783699591283081216
author Kim, Suree
Heo, Sukyeong
Brzostowski, Joseph
Kang, Dongmin
author_facet Kim, Suree
Heo, Sukyeong
Brzostowski, Joseph
Kang, Dongmin
author_sort Kim, Suree
collection PubMed
description SIMPLE SUMMARY: The full activation of AKT, which is necessary for cell physiological changes, is achieved through the phosphorylation of Thr308 and Ser473 in human AKT. Here, we have addressed how AKT activation at early endosomes occurs during growth factor stimulation and how mTORC2 is recruited into endosomes and associated with AKT. The explanation comes from the discovery of three important events: (1) the physical association of mSIN and Rictor, critical components for mTORC2 assembly and activity, with early endosomes; (2) the control of the recruitment of mSIN to endosomes by PtdIns(3,4)P(2); and (3) the PtdIns(3,4)P(2)-mediated endosomal AKT activation through phosphorylation at Ser473 to control a subset of AKT substrates. ABSTRACT: The serine/threonine kinase AKT is a major effector during phosphatidylinositol 3-kinase (PI3K)-driven cell signal transduction in response to extracellular stimuli. AKT activation mechanisms have been extensively studied; however, the mechanism underlying target of rapamycin complex 2 (mTORC2) phosphorylation of AKT at Ser473 in the cellular endomembrane system remains to be elucidated. Here, we demonstrate that endocytosis is required for AKT activation through phosphorylation at Ser473 via mTORC2 using platelet-derived growth factor-stimulated U87MG glioma cells. mTORC2 components are localized to early endosomes during growth factor activation, and the association of mTORC2 with early endosomes is responsible for the local activation of AKT, which is critical for specific signal transduction through glycogen synthase kinase-3 beta and forkhead box O1/O3 phosphorylation. Furthermore, endosomal phosphoinositide, represented by PtdIns(3,4)P(2), provides a binding platform for mTORC2 to phosphorylate AKT Ser473 in endosomes through mammalian Sty1/Spc1-interacting protein (mSIN), a pleckstrin homology domain-containing protein, and is dispensable for AKT phosphorylation at Thr308. This PtdIns(3,4)P(2)-mediated endosomal AKT activation provides a means to integrate PI3K activated by diverse stimuli to mTORC2 assembly. These early endosomal events induced by endocytosis, together with the previously identified AKT activation by PtdIns(3,4,5)P(3), contribute to the strengthening of the transduction of AKT signaling through phosphoinositide.
format Online
Article
Text
id pubmed-8157044
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81570442021-05-28 Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells Kim, Suree Heo, Sukyeong Brzostowski, Joseph Kang, Dongmin Cancers (Basel) Article SIMPLE SUMMARY: The full activation of AKT, which is necessary for cell physiological changes, is achieved through the phosphorylation of Thr308 and Ser473 in human AKT. Here, we have addressed how AKT activation at early endosomes occurs during growth factor stimulation and how mTORC2 is recruited into endosomes and associated with AKT. The explanation comes from the discovery of three important events: (1) the physical association of mSIN and Rictor, critical components for mTORC2 assembly and activity, with early endosomes; (2) the control of the recruitment of mSIN to endosomes by PtdIns(3,4)P(2); and (3) the PtdIns(3,4)P(2)-mediated endosomal AKT activation through phosphorylation at Ser473 to control a subset of AKT substrates. ABSTRACT: The serine/threonine kinase AKT is a major effector during phosphatidylinositol 3-kinase (PI3K)-driven cell signal transduction in response to extracellular stimuli. AKT activation mechanisms have been extensively studied; however, the mechanism underlying target of rapamycin complex 2 (mTORC2) phosphorylation of AKT at Ser473 in the cellular endomembrane system remains to be elucidated. Here, we demonstrate that endocytosis is required for AKT activation through phosphorylation at Ser473 via mTORC2 using platelet-derived growth factor-stimulated U87MG glioma cells. mTORC2 components are localized to early endosomes during growth factor activation, and the association of mTORC2 with early endosomes is responsible for the local activation of AKT, which is critical for specific signal transduction through glycogen synthase kinase-3 beta and forkhead box O1/O3 phosphorylation. Furthermore, endosomal phosphoinositide, represented by PtdIns(3,4)P(2), provides a binding platform for mTORC2 to phosphorylate AKT Ser473 in endosomes through mammalian Sty1/Spc1-interacting protein (mSIN), a pleckstrin homology domain-containing protein, and is dispensable for AKT phosphorylation at Thr308. This PtdIns(3,4)P(2)-mediated endosomal AKT activation provides a means to integrate PI3K activated by diverse stimuli to mTORC2 assembly. These early endosomal events induced by endocytosis, together with the previously identified AKT activation by PtdIns(3,4,5)P(3), contribute to the strengthening of the transduction of AKT signaling through phosphoinositide. MDPI 2021-05-16 /pmc/articles/PMC8157044/ /pubmed/34065746 http://dx.doi.org/10.3390/cancers13102405 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Suree
Heo, Sukyeong
Brzostowski, Joseph
Kang, Dongmin
Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title_full Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title_fullStr Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title_full_unstemmed Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title_short Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells
title_sort endosomal mtorc2 is required for phosphoinositide-dependent akt activation in platelet-derived growth factor-stimulated glioma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157044/
https://www.ncbi.nlm.nih.gov/pubmed/34065746
http://dx.doi.org/10.3390/cancers13102405
work_keys_str_mv AT kimsuree endosomalmtorc2isrequiredforphosphoinositidedependentaktactivationinplateletderivedgrowthfactorstimulatedgliomacells
AT heosukyeong endosomalmtorc2isrequiredforphosphoinositidedependentaktactivationinplateletderivedgrowthfactorstimulatedgliomacells
AT brzostowskijoseph endosomalmtorc2isrequiredforphosphoinositidedependentaktactivationinplateletderivedgrowthfactorstimulatedgliomacells
AT kangdongmin endosomalmtorc2isrequiredforphosphoinositidedependentaktactivationinplateletderivedgrowthfactorstimulatedgliomacells